We have observed
6 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after February 22, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
TREATMENT REGIMENS USING MULTIPLE PHARMACEUTICAL AGENTS
COMBINATION OF KINASE INHIBITORS AND USES THEREOF
KINASE INHIBITOR POLYMORPHS
HETEROCYCLIC COMPOUNDS AND USES THEREOF
PHARMACEUTICAL COMPOSITIONS FOR TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA, RESTORING SINUS RHYTHM, PREVENTING RECURRENCE OF CARDIAC ARRHYTHMIA AND/OR MAINTAINING NORMAL SINUS RHYTHM IN MAMMALS
Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof